
Achieving compliance with the European Pediatric Regulation requires the compilation of the pediatric effects described in the marketing authorizations for all the medicines. The highly demanding timetable has forced certain laboratories to create a veritable task force.
A world leader in the pharmaceutical sector, R&D department (Regulatory Affairs).
To respond to the obligations arising from the new European Pediatric Regulation concerning the pediatric effects of medicines.
To ensure the compliance of the Client’s operations with a major regulatory evolution.
In the context of achieving compliance with the European Pediatric Regulation, regarding the methodology applied and using all the necessary IT tools, the task was as follows :
2 scientific post graduate skilled in foreign languages, on an “in-sourcing” bases during 6 months.
The compliance of the Client’s RA database with the European Pediatric Population.
Monday 30.01.2012
Conférence à Paris: ProductLife participe à l'évènement sur la Cosmétovigilance organisé par la FEBEA
Read more
Tuesday 24.01.2012
Kompaktseminar in Berlin: EVMPD - praktische Umsetzung bis Juli 2012
Read more
Friday 20.01.2012
Petit-déjeuner à Paris: La gestion globale de l'information des produits pharmaceutiques
Read more